文献速递肝病

酒精相关肝病中肝细胞去分化特征分析确定CXCR4为细胞重编程驱动因子

Hepatocyte dedifferentiation profiling in alcohol-related liver disease identifies CXCR4 as a driver of cell reprogramming.
PubMed 文献 · J Hepatol · 2023-04-23

该研究在酒精相关肝病患者肝活检中定量分析了肝细胞-胆管(HB)表型细胞和胆管反应(DR)细胞,发现失代偿期肝硬化和酒精性肝炎(AH)患者中HB和DR细胞增多,但仅HB细胞与肝功能差和患者结局相关。HB细胞转录组富集CXCR4通路,小鼠实验表明CXCR4过表达促进肝损伤和去分化,而敲除或药物抑制CXCR4可改善去分化并减少DR和纤维化进展。

要点

  • 失代偿期肝硬化和AH患者肝内HB细胞和DR细胞增多,但仅HB细胞与肝功能差及患者结局相关。
  • HB细胞表达胆管特异性基因并轻度下调肝细胞代谢,CXCR4通路高度富集且与疾病严重度和去分化相关。
  • 小鼠肝内CXCR4过表达降低肝细胞特异性基因表达并促进肝损伤,CXCR4缺失或药物抑制改善去分化并减少DR和纤维化进展。

核心结论

  • 肝细胞去分化与AH疾病进展和不良结局相关。
  • HB细胞转录组分析揭示CXCR4是肝细胞向胆管重编程的新驱动因子,并可能是阻止AH肝细胞去分化的潜在治疗靶点。

研究设计与样本

  • 研究对酒精相关肝病患者肝活检中的HB细胞和DR细胞进行定量和显微切割。
  • 在小鼠肝损伤模型中评估肝细胞特异性过表达或缺失CXCR4以及CXCR4药理抑制的效果。
  • 生成患者来源和小鼠类器官以评估可塑性。

主要发现

  • 失代偿期肝硬化和AH患者中HB细胞和DR细胞增加,但仅HB细胞与肝功能差和患者结局相关。
  • HB细胞转录组显示胆管特异性基因表达和肝细胞代谢轻度降低,功能分析识别出肝细胞重编程、炎症、干性和癌症基因程序相关通路。
  • CXCR4通路在HB细胞中高度富集,并与疾病严重度和肝细胞去分化相关。
  • 体外实验中CXCR4与胆管表型和肝细胞特征丢失相关。
  • 慢性肝损伤小鼠肝内过表达CXCR4降低肝细胞特异性基因表达谱并促进肝损伤;CXCR4缺失或药理抑制改善肝细胞去分化并减少DR和纤维化进展。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Loss of hepatocyte identity is associated with impaired liver function in alcohol-related hepatitis (AH). In this context, hepatocyte dedifferentiation gives rise to cells with a hepatobiliary (HB) phenotype expressing biliary and hepatocyte markers and showing immature features. However, the mechanisms and impact of hepatocyte dedifferentiation in liver disease are poorly understood. METHODS: HB cells and ductular reaction (DR) cells were quantified and microdissected from liver biopsies from patients with alcohol-related liver disease (ArLD). Hepatocyte-specific overexpression or deletion of C-X-C motif chemokine receptor 4 (CXCR4), and CXCR4 pharmacological inhibition were assessed in mouse liver injury. Patient-derived and mouse organoids were generated to assess plasticity. RESULTS: Here, we show that HB and DR cells are increased in patients with decompensated cirrhosis and AH, but only HB cells correlate with poor liver function and patients' outcome. Transcriptomic profiling of HB cells revealed the expression of biliary-specific genes and a mild reduction of hepatocyte metabolism. Functional analysis identified pathways involved in hepatocyte reprogramming, inflammation, stemness, and cancer gene programs. The CXCR4 pathway was highly enriched in HB cells and correlated with disease severity and hepatocyte dedifferentiation. In vitro, CXCR4 was associated with a biliary phenotype and loss of hepatocyte features. Liver overexpression of CXCR4 in chronic liver injury decreased the hepatocyte-specific gene expression profile and promoted liver injury. CXCR4 deletion or its pharmacological inhibition ameliorated hepatocyte dedifferentiation and reduced DR and fibrosis progression. CONCLUSIONS: This study shows the association of hepatocyte dedifferentiation with disease progression and poor outcome in AH. Moreover, the transcriptomic profiling of HB cells revealed CXCR4 as a new driver of hepatocyte-to-biliary reprogramming and as a potential therapeutic target to halt hepatocyte dedifferentiation in AH. IMPACT AND IMPLICATIONS: Here, we show that hepatocyte dedifferentiation is associated with disease severity and a reduced synthetic capacity of the liver. Moreover, we identify the CXCR4 pathway as a driver of hepatocyte dedifferentiation and as a therapeutic target in alcohol-related hepatitis. Therefore, this study reveals the importance of preserving strict control over hepatocyte plasticity in order to preserve liver function and promote tissue repair.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Aguilar-Bravo B, Ariño S, Blaya D, et al. Hepatocyte dedifferentiation profiling in alcohol-related liver disease identifies CXCR4 as a driver of cell reprogramming. J Hepatol. 2023. PMID: 37088308. doi:10.1016/j.jhep.2023.04.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。